期刊文献+

恶性胶质瘤的放射治疗 被引量:5

下载PDF
导出
摘要 恶性胶质瘤是成人中枢神经系统最常见的原发性恶性肿瘤,生存率低,易复发。治疗采取以手术治疗为主,结合放疗、化疗等疗法的综合治疗。手术可以缓解临床症状,延长生存期,明确病理诊断,减轻瘤负荷。但瘤体呈浸润性生长,具体边界并不清楚,术后几乎均复发,引进放射治疗后,杀灭或抑制术后残存肿瘤,延长了生存期。如今手术加放疗已成为标准的治疗方式。本文就放射治疗中存在争议的几个问题做了讨论,以望提高治疗效果。
作者 康文星
机构地区 解放军
出处 《现代肿瘤医学》 CAS 2012年第5期1076-1078,共3页 Journal of Modern Oncology
  • 相关文献

参考文献23

  • 1NICE technology appraisal guidance 121.Carmustine implants and temozolomide for the treatment of newly diagnosed high-grade gli-oma[J].Nat Inst Clin Excel,J2007,6:3.
  • 2Davis FG,Kupelian V,Freels S,et al.Prevalence estimates for pri-mary brain tumors in the United States by behavior and major his-tology groups[J].Neurooncology,2001;3:152-158.
  • 3Walker MD,Green SB,Byar DP,et al.Randomized comparison ofradiotherapy and nitrosoureas for the malignant glioma after surgery[J].N Eng J Med,1980,303:1323-1329.
  • 4Kita M,Okawa T,Tanaka M,et al.Radiotherapy of malignant glio-ma-prospective randomized clinical study of whole brain vs localirradiation[J].Gan No Rinsho,1989,35:1289-1294.
  • 5Croteau D,Scarpace L,Hearshen D,et al.Correlation between mag-netic resonance spectroscopy imaging and image-guided biopsies:semiquantitative and qualitative histopathological analyses of pa-tients with untreated glioma[J].Neurosurgery,2001,49:823-829.
  • 6胡裕效,朱虹.^(11)C-MET PET显像在脑胶质瘤中的应用进展[J].放射学实践,2010,25(11):1293-1295. 被引量:6
  • 7GrosuAL,Weber WA,Franz M,et al.Re-irradiation of recurrent highgrade gliomas using amino-acids-PET(SPECT)/CT/MRI imagefusion to determine gross tumor volume for stereotactic fractionatedradiotherapy[J].Int J Raiat Oncol Biol Phys,2005,63:511-519.
  • 8Bleehen NM,Stenning SP.A Medical Research Council trial of tworadiotherapy doses in the treatment of grades 3 and 4 astrocytoma.The Medical Research Council Brain Tumour Working Party[J].BrJ Cancer,1991,64(4):769-774.
  • 9Chan JL,Lee SW,Fraass BA,et al.Survival and failure patterns ofhigh-grade glioma after three-dimensional conformal radiothera-py[J].J Clin Oncol,2002,20:1635-1642.
  • 10姜炜,郭阳,张文学,张春智.立体定向放疗与常规放疗结合治疗高分级脑胶质瘤[J].中华神经外科杂志,2006,22(5):271-274. 被引量:9

二级参考文献68

  • 1蔡莉,高硕.PET在脑肿瘤复发与放射性坏死鉴别诊断中的价值[J].中国肿瘤临床,2004,31(19):1134-1137. 被引量:8
  • 2邓印辉,何咏,梁舜尧,黄敏仪,李凯.伽玛刀治疗脑胶质瘤的临床分析(附142例临床报道)[J].立体定向和功能性神经外科杂志,2005,18(6):329-331. 被引量:5
  • 3涂兰波,梁军潮,王伟民.伽玛刀治疗脑胶质瘤进展[J].立体定向和功能性神经外科杂志,2005,18(6):374-376. 被引量:8
  • 4Chfibbaro S, Benvenuti L, Caprio A, et al. Temozolomide as first 1 ine agent in treating high grade gliomas: phase Ⅱ study[ J]. Neurooncol, 2004, 67( 1 ) : 77 -81.
  • 5Nagane M, Kobayashi K, Ohnishi A, et al. Prognostic significance of O6-methylguanine-DNA methyltransferase protein expression in patients with recurrent glioblastoma treated with temozolomide[J]. Clin Oncol, 2007, 37(12):897-906.
  • 6Esteller M, Garcia-Foncillas J, Andion E, et al. Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. N Engl J Med. 2000, 343(19) :1350 -1354.
  • 7Stupp R, Hegi ME, Gilbert MR, et al. Chemoradiotherapy in malignant glioma : standard of care and future directions [ J ]. Clin Oncol, 2007, 25(26): 4127-4136.
  • 8Cavaliere R, Wen PY, Schiff D. Novel therapies for malignant gliomas[J]. Neurol Clin, 2007, 25(4) : 1141 -1171.
  • 9Hegi ME, Diserens AC, Gorlia T, et al. MGMT gene silencing and benefit from temozolomide in glioblastoma [ J ]. N Engl Med, 2005, 352(10) :997 - 1003.
  • 10Vera K, Djafari L, Faivre S, et al. Dose-dense regimen of temozolomide given every other week in patients with primary central nervous system tumors[JJ. Ann Oncol, 2004, 15( 1 ) :161 -171

共引文献68

同被引文献46

引证文献5

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部